Publisher: Icon Group International, Inc.
Category: Drug Discovery

Drug Discovery market research reports by Icon Group International, Inc.

(361 reports matching your criteria)
    • The 2025-2030 World Outlook for Breast Cancer Drugs

      The 2025-2030 World Outlook for Breast Cancer Drugs This study covers the world outlook for breast cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More

    • The 2025-2030 World Outlook for Type 1 Spinal Muscular Atrophy

      The 2025-2030 World Outlook for Type 1 Spinal Muscular Atrophy This study covers the world outlook for type 1 spinal muscular atrophy across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More

    • The 2025-2030 World Outlook for Artemisinin Combination

      The 2025-2030 World Outlook for Artemisinin Combination This study covers the world outlook for artemisinin combination across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More

    • The 2025-2030 World Outlook for Pain Therapeutics

      The 2025-2030 World Outlook for Pain Therapeutics This study covers the world outlook for pain therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More

    • The 2025-2030 World Outlook for Uveitis Drugs

      The 2025-2030 World Outlook for Uveitis Drugs This study covers the world outlook for uveitis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), t ... Read More

    • The 2025-2030 World Outlook for Cutaneous Melanoma Therapeutics

      The 2025-2030 World Outlook for Cutaneous Melanoma Therapeutics This study covers the world outlook for cutaneous melanoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Erectile Dysfunction Therapeutics

      The 2025-2030 World Outlook for Erectile Dysfunction Therapeutics This study covers the world outlook for erectile dysfunction therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More

    • The 2025-2030 World Outlook for Small Molecule Drug Discovery Technologies

      The 2025-2030 World Outlook for Small Molecule Drug Discovery Technologies This study covers the world outlook for small molecule drug discovery technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More

    • The 2025-2030 World Outlook for Opioid Induced Constipation Drugs

      The 2025-2030 World Outlook for Opioid Induced Constipation Drugs This study covers the world outlook for opioid induced constipation drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More

    • The 2025-2030 World Outlook for Anti-Rejection Drugs and Immunosuppressants for Liver Diseases Treatments

      The 2025-2030 World Outlook for Anti-Rejection Drugs and Immunosuppressants for Liver Diseases Treatments This study covers the world outlook for anti-rejection drugs and immunosuppressants for liver diseases treatments across more than 190 countries. For each year reported, estimates are given for ... Read More

    • The 2025-2030 World Outlook for Psoriasis Medicines

      The 2025-2030 World Outlook for Psoriasis Medicines This study covers the world outlook for psoriasis medicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More

    • The 2025-2030 World Outlook for End Stage Renal Diseases

      The 2025-2030 World Outlook for End Stage Renal Diseases This study covers the world outlook for end stage renal diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Osteoporosis Drugs

      The 2025-2030 World Outlook for Osteoporosis Drugs This study covers the world outlook for osteoporosis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More

    • The 2025-2030 World Outlook for Ulcerative Colitis

      The 2025-2030 World Outlook for Ulcerative Colitis This study covers the world outlook for ulcerative colitis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More

    • The 2025-2030 World Outlook for Psoriatic Arthritis Therapeutics

      The 2025-2030 World Outlook for Psoriatic Arthritis Therapeutics This study covers the world outlook for psoriatic arthritis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More

    • The 2025-2030 World Outlook for Topical Vitiligo Therapeutics

      The 2025-2030 World Outlook for Topical Vitiligo Therapeutics This study covers the world outlook for topical vitiligo therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

    • The 2025-2030 World Outlook for Thin Film Drugs

      The 2025-2030 World Outlook for Thin Film Drugs This study covers the world outlook for thin film drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More

    • The 2025-2030 World Outlook for Antiepileptic Therapeutics for Fibromyalgia

      The 2025-2030 World Outlook for Antiepileptic Therapeutics for Fibromyalgia This study covers the world outlook for antiepileptic therapeutics for fibromyalgia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More

    • The 2025-2030 World Outlook for Inflammatory Bowel Disease Treatments

      The 2025-2030 World Outlook for Inflammatory Bowel Disease Treatments This study covers the world outlook for inflammatory bowel disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More

    • The 2025-2030 World Outlook for Progestogens for Cancer Cachexia

      The 2025-2030 World Outlook for Progestogens for Cancer Cachexia This study covers the world outlook for progestogens for cancer cachexia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More

    • The 2025-2030 World Outlook for Angina Pectoris Drugs

      The 2025-2030 World Outlook for Angina Pectoris Drugs This study covers the world outlook for angina pectoris drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Osteoarthritis Drugs

      The 2025-2030 World Outlook for Osteoarthritis Drugs This study covers the world outlook for osteoarthritis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More

    • The 2025-2030 World Outlook for Migraine Drugs

      The 2025-2030 World Outlook for Migraine Drugs This study covers the world outlook for migraine drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), ... Read More

    • The 2025-2030 World Outlook for Bladder Cancer Therapeutics

      The 2025-2030 World Outlook for Bladder Cancer Therapeutics This study covers the world outlook for bladder cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More

    • The 2025-2030 World Outlook for Multiple Myeloma Therapeutics

      The 2025-2030 World Outlook for Multiple Myeloma Therapeutics This study covers the world outlook for multiple myeloma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

1 2 3 4 5 6 7 8 9 10

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings